Silence Therapeutics (SLN) Welcomes Tim McInerney to Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. SPY
2. PCVX
3. NVDA
4. KLC
5. TSLA
6. PTC
7. CME
8. USO
9. AMD
10. EVTL

Go back to Silence Therapeutics (SLN) Welcomes Tim McInerney to Board of Directors

Silence Therapeutics Welcomes Tim McInerney to Board of Directors

May 6, 2025 7:45 AM EDT

Mr. McInerney brings over 30 years of industry experience spanning senior executive, finance and capital advisory roles in the pharmaceutical and biotechnology sectors

LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, Nasdaq: SLN (Silence or the Company), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced the appointment of Tim McInerney to the Companys Board of Directors, effective immediately. Mr. McInerney will stand for re-appointment to the Silence Board at the Annual General Meeting (AGM) in June 2025.

We are thrilled to welcome Tim to the Silence Board, said Iain Ross, Chairman of the Silence... More